766728007: Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Histamine receptor antagonist-containing product\Product containing ethanolamine derivative and histamine receptor antagonist (product)\Product containing phenyltoloxamine (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\...

\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Product containing ethanolamine derivative and histamine receptor antagonist (product)\Product containing phenyltoloxamine (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Product containing ethanolamine derivative and histamine receptor antagonist (product)\Product containing phenyltoloxamine (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing paracetamol (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing paracetamol (medicinal product)\Paracetamol- and phenyltoloxamine-containing product\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product manufactured as oral dose form (product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3662412011 Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3662414012 Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3681712017 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3662412011 Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3662414012 Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3681711012 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3681712017 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Conventional release oral tablet (dose form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	500	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Paracetamol	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Phenyltoloxamine citrate	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	30	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Phenyltoloxamine citrate	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Paracetamol	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Phenyltoloxamine citrate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Phenyltoloxamine citrate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Paracetamol	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Paracetamol	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3662412011	Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3662414012	Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3681712017	Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3662412011	Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3662414012	Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3681711012	Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3681712017	Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core